The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global MSD Treatment Market Research Report 2024
Synopsis
Musculoskeletal Disorders or MSDs are injuries anddisorders that affect the human body's movement ormusculoskeletal system (i.e. muscles, tendons, ligaments, nerves, discs, blood vessels, etc.). Common MSDs include: Carpal Tunnel Syndrome. Tendonitis. Muscle / Tendon
The global MSD Treatment market was valued at US$ 82410 million in 2023 and is anticipated to reach US$ 110750 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
The Musculoskeletal Disorders Drugs market refers to the pharmaceuticals and medications used for the treatment of disorders and diseases related to the musculoskeletal system, including arthritis, osteoporosis, and musculoskeletal pain. This market encompasses various therapeutic areas such as nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, disease-modifying antirheumatic drugs (DMARDs), and bone health medications. The Musculoskeletal Disorders Drugs market has been witnessing steady growth due to factors such as the aging population, increasing prevalence of musculoskeletal disorders, and advancements in drug development. Key players in the market include pharmaceutical companies, biotechnology firms, and generic drug manufacturers. Geographically, North America holds a significant market share, followed by Europe. However, the market in Asia Pacific is expected to witness substantial growth in the coming years, driven by the rising incidence of musculoskeletal disorders and improving access to healthcare.
This report aims to provide a comprehensive presentation of the global market for MSD Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding MSD Treatment.
Report Scope
The MSD Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global MSD Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the MSD Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Amgen
Johnson & Johnson
Roche
Pfizer Inc
Eli Lilly
Merck
Novartis
UCB
Segment by Type
OTC
Rx Drugs
Segment by Application
Hospital
Retail Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of MSD Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Musculoskeletal Disorders or MSDs are injuries anddisorders that affect the human body's movement ormusculoskeletal system (i.e. muscles, tendons, ligaments, nerves, discs, blood vessels, etc.). Common MSDs include: Carpal Tunnel Syndrome. Tendonitis. Muscle / Tendon
The global MSD Treatment market was valued at US$ 82410 million in 2023 and is anticipated to reach US$ 110750 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
The Musculoskeletal Disorders Drugs market refers to the pharmaceuticals and medications used for the treatment of disorders and diseases related to the musculoskeletal system, including arthritis, osteoporosis, and musculoskeletal pain. This market encompasses various therapeutic areas such as nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, disease-modifying antirheumatic drugs (DMARDs), and bone health medications. The Musculoskeletal Disorders Drugs market has been witnessing steady growth due to factors such as the aging population, increasing prevalence of musculoskeletal disorders, and advancements in drug development. Key players in the market include pharmaceutical companies, biotechnology firms, and generic drug manufacturers. Geographically, North America holds a significant market share, followed by Europe. However, the market in Asia Pacific is expected to witness substantial growth in the coming years, driven by the rising incidence of musculoskeletal disorders and improving access to healthcare.
This report aims to provide a comprehensive presentation of the global market for MSD Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding MSD Treatment.
Report Scope
The MSD Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global MSD Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the MSD Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Amgen
Johnson & Johnson
Roche
Pfizer Inc
Eli Lilly
Merck
Novartis
UCB
Segment by Type
OTC
Rx Drugs
Segment by Application
Hospital
Retail Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of MSD Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global MSD Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Market by Application
1.3.1 Global MSD Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global MSD Treatment Market Perspective (2019-2030)
2.2 MSD Treatment Growth Trends by Region
2.2.1 Global MSD Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 MSD Treatment Historic Market Size by Region (2019-2024)
2.2.3 MSD Treatment Forecasted Market Size by Region (2025-2030)
2.3 MSD Treatment Market Dynamics
2.3.1 MSD Treatment Industry Trends
2.3.2 MSD Treatment Market Drivers
2.3.3 MSD Treatment Market Challenges
2.3.4 MSD Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top MSD Treatment Players by Revenue
3.1.1 Global Top MSD Treatment Players by Revenue (2019-2024)
3.1.2 Global MSD Treatment Revenue Market Share by Players (2019-2024)
3.2 Global MSD Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by MSD Treatment Revenue
3.4 Global MSD Treatment Market Concentration Ratio
3.4.1 Global MSD Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by MSD Treatment Revenue in 2023
3.5 MSD Treatment Key Players Head office and Area Served
3.6 Key Players MSD Treatment Product Solution and Service
3.7 Date of Enter into MSD Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 MSD Treatment Breakdown Data by Type
4.1 Global MSD Treatment Historic Market Size by Type (2019-2024)
4.2 Global MSD Treatment Forecasted Market Size by Type (2025-2030)
5 MSD Treatment Breakdown Data by Application
5.1 Global MSD Treatment Historic Market Size by Application (2019-2024)
5.2 Global MSD Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America MSD Treatment Market Size (2019-2030)
6.2 North America MSD Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America MSD Treatment Market Size by Country (2019-2024)
6.4 North America MSD Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe MSD Treatment Market Size (2019-2030)
7.2 Europe MSD Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe MSD Treatment Market Size by Country (2019-2024)
7.4 Europe MSD Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific MSD Treatment Market Size (2019-2030)
8.2 Asia-Pacific MSD Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific MSD Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific MSD Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America MSD Treatment Market Size (2019-2030)
9.2 Latin America MSD Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America MSD Treatment Market Size by Country (2019-2024)
9.4 Latin America MSD Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa MSD Treatment Market Size (2019-2030)
10.2 Middle East & Africa MSD Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa MSD Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa MSD Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie MSD Treatment Introduction
11.1.4 AbbVie Revenue in MSD Treatment Business (2019-2024)
11.1.5 AbbVie Recent Development
11.2 Amgen
11.2.1 Amgen Company Detail
11.2.2 Amgen Business Overview
11.2.3 Amgen MSD Treatment Introduction
11.2.4 Amgen Revenue in MSD Treatment Business (2019-2024)
11.2.5 Amgen Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson MSD Treatment Introduction
11.3.4 Johnson & Johnson Revenue in MSD Treatment Business (2019-2024)
11.3.5 Johnson & Johnson Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche MSD Treatment Introduction
11.4.4 Roche Revenue in MSD Treatment Business (2019-2024)
11.4.5 Roche Recent Development
11.5 Pfizer Inc
11.5.1 Pfizer Inc Company Detail
11.5.2 Pfizer Inc Business Overview
11.5.3 Pfizer Inc MSD Treatment Introduction
11.5.4 Pfizer Inc Revenue in MSD Treatment Business (2019-2024)
11.5.5 Pfizer Inc Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Detail
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly MSD Treatment Introduction
11.6.4 Eli Lilly Revenue in MSD Treatment Business (2019-2024)
11.6.5 Eli Lilly Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck MSD Treatment Introduction
11.7.4 Merck Revenue in MSD Treatment Business (2019-2024)
11.7.5 Merck Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis MSD Treatment Introduction
11.8.4 Novartis Revenue in MSD Treatment Business (2019-2024)
11.8.5 Novartis Recent Development
11.9 UCB
11.9.1 UCB Company Detail
11.9.2 UCB Business Overview
11.9.3 UCB MSD Treatment Introduction
11.9.4 UCB Revenue in MSD Treatment Business (2019-2024)
11.9.5 UCB Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
